Fineline Cube

Follow:
14486 Articles
Frontera Therapeutics Receives FDA Approval for Phase II Study of FT-003 in nAMD
CompanyDrug

Frontera Therapeutics Receives FDA Approval for Phase II Study of FT-003 in nAMD

Viatris Reports Q3 2024 Global Sales of USD 3.8 Billion with a 5% YOY Decline
Company

Viatris Reports Q3 2024 Global Sales of USD 3.8 Billion with a 5% YOY Decline

Gilead Sciences Reports 7% YOY Increase in Q3 2024 Product Sales, Driven by HIV Therapies
Company

Gilead Sciences Reports 7% YOY Increase in Q3 2024 Product Sales, Driven by HIV Therapies

GSK Leaves BIO, Joining Other Major Companies in Withdrawing Membership
Company

GSK Leaves BIO, Joining Other Major Companies in Withdrawing Membership

ATLATL and Takeda Enter MoU to Collaborate on Early-Stage Drug Development and Innovation
CompanyDeals

ATLATL and Takeda Enter MoU to Collaborate on Early-Stage Drug Development and Innovation

Alteogen Secures Exclusive Licensing Deal with Daiichi Sankyo for Subcutaneous Enhertu
CompanyDeals

Alteogen Secures Exclusive Licensing Deal with Daiichi Sankyo for Subcutaneous Enhertu

Baheal Pharmaceutical Group Leads USD 78 Million Investment in ZAP Surgical Systems
CompanyDeals

Baheal Pharmaceutical Group Leads USD 78 Million Investment in ZAP Surgical Systems

Pfizer Partners with Beijing Mabworks and KYinno Biotechnology on Multiple Myeloma Treatments in China
CompanyDeals

Pfizer Partners with Beijing Mabworks and KYinno Biotechnology on Multiple Myeloma Treatments in China

AstraZeneca's Tezspire Meets Phase III Co-Primary Endpoints in CRSwNP Study
CompanyDrug

AstraZeneca’s Tezspire Meets Phase III Co-Primary Endpoints in CRSwNP Study

Sino Medical Sciences Technology Secures Marketing Approval in Peru for HT Supreme Stent System
CompanyMedical Device

Sino Medical Sciences Technology Secures Marketing Approval in Peru for HT Supreme Stent System

Jiangsu Kanion Pharmaceutical Gets FDA Approval to Test KYS202004A for Psoriasis
CompanyDrug

Jiangsu Kanion Pharmaceutical Gets FDA Approval to Test KYS202004A for Psoriasis

J&J Submits Regulatory Filings for Darzalex Faspro and Subcutaneous Daratumumab
CompanyDrug

J&J Submits Regulatory Filings for Darzalex Faspro and Subcutaneous Daratumumab